JACOB WOLFF: Open Payments
NPI 1164513305 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,194 in 61 payments from 14 companies in 2025. Trend: 2023 $1,982 · 2024 $1,794 · 2025 $1,194
Food & beverage: $1,098Education: $96
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $247 |
| Janssen Biotech, Inc. | 17 | $221 |
| LEO Pharma Inc. | 4 | $98 |
| ABBVIE INC. | 4 | $92 |
| Lilly USA, LLC | 4 | $87 |
| Galderma Laboratories, L.P. | 4 | $81 |
| UCB, Inc. | 4 | $69 |
| Amgen Inc. | 3 | $53 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $51 |
| Arcutis Biotherapeutics, Inc. | 3 | $48 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, ADBRY, Bimzelx, RINVOQ, OTEZLA, Zoryve.
Industry payments across WA — which companies pay providers there.
